Jundishapur Journal of Microbiology

Published by: Kowsar

Baculoviral Co-Expression of HA, NA and M1 Proteins of Highly Pathogenic H5N1 Influenza Virus in Insect Cells

Farida Behzadian 1 , Zahra Goodarzi 2 , Fatemeh Fotouhi 3 and Esmaeil Saberfar 2 , *
Authors Information
1 Malek Ashtar University, Research Center for Sciences and Biotechnology, Tehran, IR Iran
2 Applied Virology Research Center, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
3 Influenza Research Labs, Pasteur Institute of Iran, Tehran, IR Iran
Article information
  • Jundishapur Journal of Microbiology: November 01, 2013, 6 (9); e7665
  • Published Online: November 1, 2013
  • Article Type: Research Article
  • Received: August 22, 2012
  • Revised: December 12, 2012
  • Accepted: January 12, 2013
  • DOI: 10.5812/jjm.7665

To Cite: Behzadian F, Goodarzi Z, Fotouhi F, Saberfar E. Baculoviral Co-Expression of HA, NA and M1 Proteins of Highly Pathogenic H5N1 Influenza Virus in Insect Cells, Jundishapur J Microbiol. 2013 ; 6(9):e7665. doi: 10.5812/jjm.7665.

Copyright © 2013, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Munster VJ, Fouchier RA. Avian influenza virus: of virus and bird ecology. Vaccine. 2009; 27(45): 6340-4[DOI][PubMed]
  • 2. Alexander Dennis J. A review of avian influenza in different bird species. Vet Microbiol. 2000; 74(1): 3-13
  • 3. Knipe DM, Howley P. Fields Virology.: 2013;
  • 4. Wen Z, Ye L, Gao Y, Pan L, Dong K, Bu Z, et al. Immunization by influenza virus-like particles protects aged mice against lethal influenza virus challenge. Antiviral Res. 2009; 84(3): 215-24[DOI][PubMed]
  • 5. Hitchman RB, Possee RD, Crombie AT, Chambers A, Ho K, Siaterli E, et al. Genetic modification of a baculovirus vector for increased expression in insect cells. Cell Biol Toxicol. 2010; 26(1): 57-68[DOI][PubMed]
  • 6. Ligon BL. Avian influenza virus H5N1: a review of its history and information regarding its potential to cause the next pandemic. Semin Pediatr Infect Dis. 2005; 16(4): 326-35[DOI][PubMed]
  • 7. Ellebedy AH, Webby RJ. Influenza vaccines. Vaccine. 2009; 27 Suppl 4-8[DOI][PubMed]
  • 8. Steel J. New strategies for the development of H5N1 subtype influenza vaccines: progress and challenges. BioDrugs. 2011; 25(5): 285-98[DOI][PubMed]
  • 9. Lambert Linda C, Fauci Anthony S. Influenza vaccines for the future. New England J Med. 2010; 363(21): 2036-2044
  • 10. Berger I, Fitzgerald DJ, Richmond TJ. Baculovirus expression system for heterologous multiprotein complexes. Nat Biotechnol. 2004; 22(12): 1583-7[DOI][PubMed]
  • 11. Bright RA, Carter DM, Daniluk S, Toapanta FR, Ahmad A, Gavrilov V, et al. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin. Vaccine. 2007; 25(19): 3871-8[DOI][PubMed]
  • 12. Kang SM, Pushko P, Bright RA, Smith G, Compans RW. Influenza virus-like particles as pandemic vaccines. Curr Top Microbiol Immunol. 2009; 333: 269-89[DOI][PubMed]
  • 13. Ludwig C, Wagner R. Virus-like particles-universal molecular toolboxes. Curr Opin Biotechnol. 2007; 18(6): 537-45[DOI][PubMed]
  • 14. Krammer F, Grabherr R. Alternative influenza vaccines made by insect cells. Trends Mol Med. 2010; 16(7): 313-20[DOI][PubMed]
  • 15. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, et al. Short Protocols in Molecular Biology.: 2002;
  • 16. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;
  • 17. Aucoin MG, Mena JA, Kamen AA. Bioprocessing of baculovirus vectors: a review. Curr Gene Ther. 2010; 10(3): 174-86[PubMed]
  • 18. Trowitzsch S, Bieniossek C, Nie Y, Garzoni F, Berger I. New baculovirus expression tools for recombinant protein complex production. J Struct Biol. 2010; 172(1): 45-54[DOI][PubMed]
  • 19. Federico Maurizio. Virus-like particles show promise as candidates for new vaccine strategies. Future virology. 2010; 5(4): 371-374
  • 20. Latham T, Galarza JM. Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins. J Virol. 2001; 75(13): 6154-65[DOI][PubMed]
  • 21. Galarza JM, Latham T, Cupo A. Virus-like particle (VLP) vaccine conferred complete protection against a lethal influenza virus challenge. Viral Immunol. 2005; 18(1): 244-51[DOI][PubMed]
  • 22. Bright RA, Carter DM, Crevar CJ, Toapanta FR, Steckbeck JD, Cole KS, et al. Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle. PLoS One. 2008; 3(1)[DOI][PubMed]
  • 23. Quan FS, Steinhauer D, Huang C, Ross TM, Compans RW, Kang SM. A bivalent influenza VLP vaccine confers complete inhibition of virus replication in lungs. Vaccine. 2008; 26(26): 3352-61[DOI][PubMed]
  • 24. Sokolenko S, George S, Wagner A, Tuladhar A, Andrich JM, Aucoin MG. Co-expression vs. co-infection using baculovirus expression vectors in insect cell culture: Benefits and drawbacks. Biotechnol Adv. 2012; 30(3): 766-81[DOI][PubMed]
  • 25. Quan FS, Huang C, Compans RW, Kang SM. Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus. J Virol. 2007; 81(7): 3514-24[DOI][PubMed]
  • 26. Kang SM, Yoo DG, Lipatov AS, Song JM, Davis CT, Quan FS, et al. Induction of long-term protective immune responses by influenza H5N1 virus-like particles. PLoS One. 2009; 4(3)[DOI][PubMed]
  • 27. Pushko P, Tumpey TM, Bu F, Knell J, Robinson R, Smith G. Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice. Vaccine. 2005; 23(50): 5751-9[DOI][PubMed]
  • 28. Pushko P, Tumpey TM, Van Hoeven N, Belser JA, Robinson R, Nathan M, et al. Evaluation of influenza virus-like particles and Novasome adjuvant as candidate vaccine for avian influenza. Vaccine. 2007; 25(21): 4283-90[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments